| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |